At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. 

Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com. 

Life Sciences

Therapeutics

Lykos Therapeutics (formerly MAPS PBC)

Michael Mullette

Dr. Berra Yazar-Klosinski

Andrew Septimus

Kacy Hutchison

Michelle Lacy

William Stewart

Blair Clark - Schoeb

Joy Sun Cooper

Berra Yazar - Klosinski

Allison Rosenthal

The Financial and Administrative Support team at Lykos Therapeutics plays a crucial role in managing the company's financial health and operational efficiency. This team is responsible for financial planning and analysis, overseeing budgeting processes, ensuring compliance, and providing strategic financial insights. Additionally, they support human resources functions, talent acquisition, and IT services, all while maintaining a commitment to the company's public benefit mission.

Financial and Administrative Support

Clinical Research and Development

Leadership Team

Financial and Administrative Support

About

Team members

Other teams at Lykos Therapeutics (formerly MAPS PBC)

Clinical Research and Development

Leadership Team